Rainbow Crops Awarded $7 Million Grant to Advance Climate-Resilient Crops

Ghent, Belgium - 4 March 2026 - Rainbow Crops, a next-generation agtech company developing crop genetics with enhanced complex agronomic traits, has been awarded a $7 million grant from the Gates Foundation. The funding will support the application of Rainbow Crops’ Trait Foundry™ platform to advance new genetic approaches for improving crop performance under heat and drought stress to meet the needs of smallholder farmers.

With the aim of progressing climate-resilient crops and improved germplasm delivery, the platform will develop innovative approaches for identifying and combining alleles to support germination under challenging climatic conditions.

Rainbow Crops’ Trait Foundry™ platform integrates multiplex genome editing, AI, breeding, and phenotyping to enable the systematic identification and combination of optimized genetic variants underlying complex agronomic traits. Unlike traditional breeding or single-gene approaches, the platform is designed to address traits controlled by multiple interacting genes, such as drought tolerance and plant vigor.

The research will initially focus on corn, sorghum, and rice - crops that are important to global food security, particularly in Sub-Saharan Africa and South Asia. The project places a strong emphasis on seedling performance under heat and drought stress, generating both scientific knowledge and trait-building blocks that can support future breeding efforts.

Rainbow Crops’ technology platform builds on years of research at VIB, a leading life sciences research institute, where the underlying scientific work was developed. As part of this collaboration, Rainbow Crops will work with the Lab of Professor Hilde Nelissen, from which Rainbow Crops was spun off, as well as with the VIB Transformation Facility & VIB Agro-Incubator.

Giacomo Bastianelli, Co-founder and CEO of Rainbow Crops, said, “This grant allows us to further strengthen our technology platform and contribute foundational advances that enable more climate-resilient crops, with relevance to regions most vulnerable to environmental change.”

The platform has already been validated end-to-end in corn, demonstrating the feasibility of Rainbow Crops’ multiplex genome editing and discovery approach across multiple traits. In addition, Rainbow Crops will collaborate with other industry partners, including coordination on scientific approaches and data sharing to accelerate collective progress.

 

About Rainbow Crops

Rainbow Crops is a next-generation agtech company developing climate-resilient, high-performing crop varieties through its proprietary Trait Foundry™ platform. By integrating multiplex genome editing, artificial intelligence, precision breeding, and automated phenotyping, Rainbow Crops enables the systematic engineering of complex agronomic traits. The company collaborates with seed and breeding partners to advance sustainable agriculture and global food security. Founded in 2025 as a spin-off from the VIB–UGent Center for Plant Systems Biology, Rainbow Crops builds on years of publicly supported research and operates within VIB’s advanced research infrastructure.

Learn more at www.rainbowcrops.com

 

 

 

 

 

Share

Latest stories

Website preview
Belgian researchers develop AI tool to improve diagnosis of rare immune disorders
Researchers from VIB and Ghent University, in close collaboration with clinicians at Ghent University Hospital, have developed PIDgeon, an explainable artificial intelligence pipeline that supports faster and more reliable diagnosis of primary immunodeficiencies (PIDs). The tool was successfully validated in nearly 1.000 patients across multiple European centers, marking an important step toward future clinical application. The study is published in Clinical Chemistry.
press.vib.be
Website preview
European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem
Brussels, Belgium, 12 February 2026 – The European Life Sciences Coalition (ELSC) has been launched to strengthen Europe’s life sciences and biotechnology VC ecosystem by mobilizing greater levels of private and public investment across the sector. Created in association with Invest Europe, the coalition brings together leading European life sciences venture capital firms, research institutions, and other stakeholders across the value chain.
press.vib.be
Website preview
Scientists discover new gatekeeper cell in the brain
Ghent, 12 February 2026 – VIB and Ghent University researchers have identified and characterized a previously unknown cellular barrier in the brain, which sheds new light on how the brain is protected from the rest of the body. In a study published in Nature Neuroscience, the scientists also reveal a new pathway by which the immune system can impact the brain.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be